Live
- Bhadrak: Four held for murder of ex-Sarpanch
- National honour for Odia chest specialist
- Sold newborn traced in Raipur
- AIBOC warns of agitation
- 4 held from Gujarat in ‘digital arrest’ case
- 10 held for attack on MLA Himanshu
- BJD refutes allegations of Adani paying bribe to officials
- Will move Supreme Court if no action over MLA disqualification; KTR
- UN committed to communicating in Hindi, will expand programme: Official
- Food Safety Task Force raids nutraceutical manufacturing units
Dr Reddy's launches skin treatment drug in US
Highlights
Dr Reddy's Laboratories on Wednesday said it launched Daptomycin for injection, used for treating complicated skin infections, in the US market.
New Delhi: Dr Reddy's Laboratories on Wednesday said it launched Daptomycin for injection, used for treating complicated skin infections, in the US market.
The company launched its product, which is generic version of Merck Sharp & Dohme Corp's Cubicin, after obtaining approval from the US Food and Drug Administration (USFDA), the pharma major said.
According to IQVIA Health, the Cubicin for injection (daptomycin for injection) brand and generics had sales of around $640.8 million for the most recent 12 months ending in March 2019.
Next Story
ADVERTISEMENT
